Patent · US Active

Crystalline forms of a compound that inhibits bromodomain

US10577366B2 · kind B2 · utility

3Cited by

71References

16Claims

0Family size

Assignee

Plexxikon Inc. · US

Inventors

Jack Lin · Hercules, US
Marika Nespi · Berkeley, US
Jason Walters · Coventry, GB

Key dates

Filing date	Mar 19, 2018
Grant date	Mar 3, 2020
Priority date	—
Expiry date	Mar 19, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Forms of 4-(1-(1,1-di(pyridin-2-yl)ethyl)-6-(3,5-dimethylisoxazol-4-yl)-1H-pyrrolo[3,2-b]pyridin-3-yl)benzoic acid were prepared and characterized in the solid state:Also provided are processes of manufacture and methods of using the forms of Compound I.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.